Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention

Alzheimer’s disease (AD) is a neurodegenerative dementia that affects nearly 50 million people worldwide and is a major source of morbidity, mortality, and healthcare expenditure. While there have been many attempts to develop disease-modifying therapies for late-onset AD, none have so far shown eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Schelke, Matthew W., Attia, Peter, Palenchar, Daniel J., Kaplan, Bob, Mureb, Monica, Ganzer, Christine A., Scheyer, Olivia, Rahman, Aneela, Kachko, Robert, Krikorian, Robert, Mosconi, Lisa, Isaacson, Richard S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907312/
https://www.ncbi.nlm.nih.gov/pubmed/29706884
http://dx.doi.org/10.3389/fnagi.2018.00096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907312/
https://www.ncbi.nlm.nih.gov/pubmed/29706884
http://dx.doi.org/10.3389/fnagi.2018.00096

Ejemplares similares